# JD Bioscience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jd-bioscience

- Industry: Biotechnology
- Headquarters: Gwangju, South Korea
- Website: www.jdbiosci.com
- Total disclosed funding: $0.1M
- Latest round: Seed (Sep 1, 2017)
- Investors on record: 2

## About

Based in Gwangju, South Korea, and founded in 2017, JD Bioscience is a biotechnology company that engages in the R&D of pharmaceuticals and ingredients of cosmetics products. JD Bioscience was founded by Jin Hee Ahn, a professor at the Gwangju Institute of Science and Technology, along with participation from researchers in KAIST, Kyungpook National University School of Medicine, and KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY. In 2018, the company contracted business agreement and received technology guarantee fund from the South Korean government. 


JD Bioscience is a R&D biotechnology company that mainly engages in the R&D of pipelines for obesity, non-alcoholic liver, and ulcerative colitis. JD Bioscience also develops functional cosmetics ingredients for anti-aging and antioxidant.

## Funding rounds

- Seed, Sep 1, 2017 — Korea Tech Incubator for Startup, Sunbo Angel Partners
- Seed, Jun 1, 2017, $0.1M — Sunbo Angel Partners

## Investors

- Sunbo Angel Partners (https://capitalatlas.ai/funds/sunbo-angel-partners) — Seed
- Korea Tech Incubator for Startup — Seed